Indian drug companies stand to benefit in the long run if the US Biosecure Act passed. The Act would restrict US federal agencies from procuring equipment and services from certain "biotechnology companies of concern", primarily some large Chinese pharma companies.
Analysts thus point out that this would impact the supply of numerous drugs used in clinical trials and critical raw materials, thereby providing opportunities for Indian companies to act as alternatives. "Green shoots are already visible as over 60 per cent of listed pharma firms have witnessed an increase in the number of enquiries for new businesses, and 33 per cent of them believe that the Act, if implemented, can be a business driver," India Ratings and Research said.
The Biosecure Act aims to protect US biopharmaceutical research by reducing federal funding for companies that partner with foreign adversaries' military or intelligence. If passed, the Act could designate specific Chinese companies as "biotechnology companies of concern". This could lead to US biopharmaceutical companies looking to diversify their suppliers before the 2032 deadline set by the Act.
India Ratings felt that Indian pharma companies operating in the contract development and manufacturing organisation (CDMO) and contract research organisation (CRO) segments are likely to reap benefits from increased orders, stemming from the passage of the US Act, from American pharma companies over the next 12-18 months.
Esta historia es de la edición July 20, 2024 de Business Standard.
Comience su prueba gratuita de Magzter GOLD de 7 días para acceder a miles de historias premium seleccionadas y a más de 9,000 revistas y periódicos.
Ya eres suscriptor ? Conectar
Esta historia es de la edición July 20, 2024 de Business Standard.
Comience su prueba gratuita de Magzter GOLD de 7 días para acceder a miles de historias premium seleccionadas y a más de 9,000 revistas y periódicos.
Ya eres suscriptor? Conectar
SOM Distilleries debuts in K'taka with Woodpecker beer
Bhopal-based SOM Distilleries and Breweries has entered the Karnataka market with \"Woodpecker\" premium beer, India's first twist cap beer.
Ambiguity over GST food rates in spotlight
The managing director (MD) of a famous restaurant chain in Tamil Nadu supposedly apologising to Union Finance Minister Nirmala Sitharaman in Coimbatore on Wednesday has triggered a political controversy.
Four states get six Vande Bharat trains
Prime Minister Narendra Modi on Sunday virtually flagged off six Vande Bharat trains for Jharkhand, Odisha, Bihar, and UP at Ranchi.
D2C brands hitch their wagon to quick-commerce
As quick commerce gains ground, emerging direct-to-consumer (D2C) brands are betting big on digital channels to drive growth.
UPS: SENSE & SENSIBILITY
As the govt embarks on a new pension scheme, what will be its fiscal implications?
Firms need time to comply with data protection law'
Companies will need time to comply with the Digital Personal Data Protection Act (DPDP) whose rules are to be released, according to VINAYAK GODSE, chief executive officer of Data Security Council of India (DSCI). It's a non-profit non-profit organisation set up by NASSCOM and works in cybersecurity and privacy. \"Companies will need to overhaul processes and adjust operations\", he said in an interview with Ashutosh Mishra in New Delhi. Edited excerpts:
There is a case for Al helping the law
The technology can assist in clearing the massive backlog in courts and in research, report ASHUTOSH MISHRA & BHAVINI MISHRA
Delaying buy decision may push costs higher amid rising prices
Pay 20-30% of cost as down payment; EMI should not exceed 40% of take-home salary
Bank not liable for lack of pledged goods cover
Shree Shakti Foam had applied to Canara Bank for a cash credit facility against the hypothecation of stocks.
India our APAC priority and primary market focus'
With markets looking forward to a rate cut by the US Federal Reserve (Fed) this week, BHASKAR LAXMINARAYAN, chief investment officer and head investment management Asia at Julius Baer, shares with Puneet Wadhwa that a 25-basis- point (bp) cut paired with a strong dovish message could be just as effective as a 50-bp cut with minimal commentary. The impact, he observes, will largely depend on the accompanying message and how it is interpreted. Edited excerpts: